Research funded in part by a biotech was retracted after a lawsuit claiming the work could not be replicated.

A prominent researcher is being sued for $1 billion by a University of Pennsylvania Cancer Institute for discoveries he may have made while a researcher and administrator there.

Editor’s choice in structural biology

Editor’s choice in immunology

Science makes a decision for the authors and retracts a paper suggesting a viral cause for chronic fatigue syndrome.

A roundup of eight biotech companies that didn’t make it through this year's continuing tough economic times

Research universities are removing the licensing fees they charged industry companies for working with their scientists.

Scientists near the Fukushima plant are equipping wild monkeys with radiation collars to get better sense of their exposure in the wild.

Researchers explain the luminous quality of yellow buttercups.

Eschewing potentially degraded DNA as a source, researchers look instead at the proteome of ancient species.

The National Institutes of Health promises about $400 million to help get personalized genetics into the clinic.

Some university presidents are earning more than ever despite their schools’ poor performance.